BIOAVAILABILITY STUDIES WITH DIGOXIN-SANDOZ AND LANOXIN

被引：17

作者：

BEVERIDGE, T

KALBERER, F

NUESCH, E

SCHMIDT, R

机构：

[1] SANDOZ LTD,EXPTL THERAPEUTICS DEPT,BIOL & MED RES DIV,BASEL,SWITZERLAND

[2] SANDOZ LTD,EXPTL THERAPEUTICS DEPT,BIOPHARM DEPT,BASEL,SWITZERLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1975年 / 8卷 / 05期

关键词：

D O I：

10.1007/BF00562665

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：371 / 376

页数：6

共 18 条

[1]

AZARNOFF DL, 1972, CLINICAL PHARMACOLOG, P41

[2]

BEVERIDGE T, 1973, LANCET, V2, P499

[3] CLINICAL PHARMACOLOGY OF DIGITALIS GLYCOSIDES - A REVIEW [J].

DOHERTY, JE .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1968, 255 (JUN) :382-&

[4] COMPARATIVE STUDY OF ABSORPTION, PLASMA LEVELS, AND URINARY-EXCRETION OF NEW AND OLD LANOXIN [J].

FALCH, D ;

TEIEN, A ;

BJERKELUND, CJ .

BMJ-BRITISH MEDICAL JOURNAL, 1973, 1 (5855) :695-697

[5] EVALUATION OF DIGOXIN BIOAVAILABILITY IN SINGLE-DOSE STUDIES [J].

GREENBLATT, DJ ;

DUHME, DW ;

KOCHWESE.J ;

SMITH, TW .

NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (13) :651-654

[6]

HUFFMAN DH, 1972, J AMER MED ASSOC, V222, P957, DOI 10.1001/jama.222.8.957

[7] BIOLOGICAL AVAILABILITY OF DIGOXIN FROM LANOXIN PRODUCED IN UNITED-KINGDOM [J].

JOHNSON, BF ;

FOWLE, ASE ;

LADER, S ;

FOX, J ;

MUNROFAU.AD .

BRITISH MEDICAL JOURNAL, 1973, 4 (5888) :323-326

[8] VARIATION IN BIOLOGIC AVAILABILITY OF DIGOXIN FROM 4 PREPARATIONS [J].

LINDENBAUM, J ;

MELLOW, MH ;

BLACKSTONE, MO ;

BUTLER, VP .

NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (24) :1344-+

[9]

MANNINEN V, 1973, LANCET, V2, P1268

[10]

MANNINEN V, 1971, LANCET, V2, P934

← 1 2 →